Your browser doesn't support javascript.
loading
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.
Zeidan, Amer M; Fenaux, Pierre; Gobbi, Marco; Mayer, Jirí; Roboz, Gail J; Krauter, Jürgen; Robak, Tadeusz; Kantarjian, Hagop M; Novák, Jan; Jedrzejczak, Wieslaw W; Thomas, Xavier; Ojeda-Uribe, Mario; Miyazaki, Yasushi; Min, Yoo Hong; Yeh, Su-Peng; Brandwein, Joseph M; Gercheva, Liana; Demeter, Judit; Griffiths, Elizabeth A; Yee, Karen W L; Issa, Jean-Pierre J; Bewersdorf, Jan Philipp; Keer, Harold; Hao, Yong; Azab, Mohammad; Döhner, Hartmut.
Afiliación
  • Zeidan AM; Section of Hematology, Department of Medicine, Yale University, New Haven, CT.
  • Fenaux P; Yale Cancer Center, New Haven, CT.
  • Gobbi M; Hôpital Saint Louis, Paris, France.
  • Mayer J; Ospedale Policlinico San Martino, Genova, Italy.
  • Roboz GJ; Fakultní Nemocnice, Brno, Czech Republic.
  • Krauter J; Division of Hematology and Medical Oncology, Weill Cornell Medicine, Cornell University, New York, NY.
  • Robak T; NewYork-Presbyterian Hospital, New York, NY.
  • Kantarjian HM; Städtisches Klinikum Braunschweig, Braunschweig, Germany.
  • Novák J; Copernicus Memorial Hospital, Lodz, Poland; Department of Hematology, Medical University of Lodz, Lodz, Poland.
  • Jedrzejczak WW; MD Anderson Cancer Center, University of Texas, Houston, TX.
  • Thomas X; Fakultní Nemocnice Královské Vinohrady, Praha, Czech Republic.
  • Ojeda-Uribe M; Uniwersyteckie Centrum Kliniczne, Warszawskiego Uniwersytetu Medycznego, Warsaw, Poland.
  • Miyazaki Y; Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Min YH; Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Mulhouse, France.
  • Yeh SP; Nagasaki University Hospital, Nagasaki, Japan.
  • Brandwein JM; Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea.
  • Gercheva L; China Medical University Hospital, Taichung, Taiwan, Republic of China.
  • Demeter J; University of Alberta Hospital, Edmonton, Canada.
  • Griffiths EA; Multiprofile Hospital for Active Treatment Sveta Marina EAD, Varna, Bulgaria.
  • Yee KWL; Semmelweis Egyetem, Budapest, Hungary.
  • Issa JJ; Roswell Park Cancer Institute, Buffalo, NY.
  • Bewersdorf JP; Princess Margaret Cancer Centre, Toronto, Canada.
  • Keer H; Coriell Institute for Medical Research, Camden, NJ.
  • Hao Y; Section of Hematology, Department of Medicine, Yale University, New Haven, CT.
  • Azab M; Yale Cancer Center, New Haven, CT.
  • Döhner H; Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
Blood ; 140(3): 285-289, 2022 07 21.
Article en En | MEDLINE | ID: mdl-35507690
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article